elvitegravir,
GS 9137,
GS-9137,
GS9137,
JTK 303,
JTK-303,
JTK303,
Vitekta,
Elvitegravir,
697761-98-1,
GS-9137,
JTK-303,
GS 9137,
Elvitegravir (GS-9137),
UNII-4GDQ854U53,
(S)-6-(3-chloro-2-fluorobenzyl)-1-(1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid,
JTK 303,
EVG,
CHEBI:72289,
CHEMBL204656,
4GDQ854U53,
6-(3-Chloro-2-fluorobenzyl)-1-[1(S)-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid,
Elvitegravir (GS-9137, JTK-303),
6-(3-chloro-2-fluorobenzyl)-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid,
6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid,
Vitekta,
6-(3-Chloro-2-fluorobenzyl)-1-((2S)-1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid,
6-(3-chloro-2-fluorobenzyl)-1-[(1S)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid,
Elvitegravir [USAN:INN],
elvitegravirum,
6-[(3-chloro-2-fluoro-phenyl)methyl]-1-[(1S)-1-(hydroxymethyl)-2-methyl-propyl]-7-methoxy-4-oxo-quinoline-3-carboxylic acid,
ELV,
Vitekta (TN),
GS9137,
PubChem19145,
AC1NQQ4E,
Elvitegravir (JAN/USAN),
Elvitegravir(GS-9137),
C23H23CLFNO5,
MLS006011136,
SCHEMBL726252,
AOB6957,
JUZYLCPPVHEVSV-LJQANCHMSA-N,
BCPP000242,
697761-98-1, Pamine,
EX-A1542,
ABP000243,
BDBM50183273,
MFCD11846134,
s2001,
ZINC13682481,
AKOS025396642,
API0007313,
BCP9000642,
CS-0439,
DB09101,
RL04670,
SB16498,
KS-0000001C,
NCGC00346565-01,
AC-29947,
AS-16986,
BC219612,
Elvitegravir,EVG,GS-9137,JTK-303/,
HY-14740,
QC-10447,
SC-93621,
SMR004702914,
AB0008021,
A4070,
FT-0667840,
SW219721-1,
X5031,
EC-000.2332,
D06677,
AB01274749-01,
AB01274749_02,
J-518006,
BRD-K54472332-001-01-8,
3-Quinolinecarboxylic acid, 6-((3-chloro-2-fluorophenyl)methyl)-1,4-dihydro-1-((1S)-1-(hydroxymethyl)-2-methylpropyl)-7-methoxy-4-oxo-,
3-Quinolinecarboxylic acid, 6-[(3-chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1S)-1-isopropyl-2-hydroxyethyl]-7-methoxy-4-oxo-,
6-(3-chloro-2-fluorobenzyl)-1-[(S)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid,
methscopolamine,
Elvitegravir [USAN],
D0QD1G,
cc-521,
JTK303,
ACN-050766,
CID5277135,
CS-O-11635,
A10347,
882534-99-8,